Government of Uzbekistan   Report issue

Government Phase 2 Phase 3
Founded: Tashkent Uzbekistan (1991)

Organization Overview

First Clinical Trial
2017
NCT02589782
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ministry of Health, Republic of Uzbekistan | Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Extensively Drug-Resistant Tuberculosis (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Multidrug-Resistant (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 6